Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $6.73 million as of March 9, 2026. Its market cap has decreased by -45.20% in one year.

Market Cap

6.73M

Enterprise Value

9.95M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 6.73M, a decrease of -94.29%. That is a compound annual growth rate of -9.62%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	6.41M	56.34%
Dec 31, 2025	4.10M	-56.61%
Dec 31, 2024	9.45M	-82.82%
Dec 29, 2023	55.03M	86.49%
Dec 30, 2022	29.51M	-73.23%
Dec 31, 2021	110.23M	-42.54%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Synlogic	6.89M
AccuStem Sciences	6.91M
TRON Group	7.38M
Brainstorm Cell Therapeutics	7.83M
Orgenesis	5.45M
Biomind Labs	8.84M
Bioxytran	4.98M
Curative Biotechnology	9.33M

Market Cap Rankings